Attenuation of human immunodeficiency virus type 1 cytopathic effect by a mutation affecting the transmembrane

M Kowalski1, L Bergeron, T Dorfman

  • 1Division of Human Retrovirology, Dana-Farber Cancer Institute, Boston, Massachusetts.

Journal of Virology
|January 1, 1991
PubMed

Insights

A mutation in the human immunodeficiency virus type 1 (HIV-1) gp41 protein significantly reduced its cytopathic effects, including syncytium formation and cell lysis. This indicates specific viral protein regions, not just viral load, drive HIV-1

Area of Science:

  • Virology
  • Molecular Biology
  • Immunology

Background:

  • Human immunodeficiency virus type 1 (HIV-1) infection causes cytopathic effects, specifically syncytium formation and single-cell lysis, in CD4 receptor-expressing cells.
  • The mechanisms driving HIV-1 cytopathicity are not fully understood, particularly the role of specific viral components beyond viral load.

Purpose of the Study:

  • To investigate the role of the amino terminus of the HIV-1 gp41 transmembrane envelope glycoprotein in mediating viral cytopathic effects.
  • To determine if mutations in gp41 affect viral replication, protein expression, or virion production while altering cytopathicity.

Main Methods:

  • Introduction of a specific mutation (517A) into the amino terminus of the HIV-1 gp41 gene.
  • Comparative analysis of the replication ability, viral protein expression, virion production, and CD4 interaction of the mutant virus versus wild-type HIV-1.
  • Assessment of syncytium formation and single-cell lysis as measures of cytopathic effect in infected cell systems.

Main Results:

  • The 517A mutant HIV-1 exhibited markedly reduced cytopathic effects compared to wild-type HIV-1.
  • Viral replication ability, protein expression, virion production, and CD4 interaction remained comparable between the 517A mutant and wild-type viruses.
  • Syncytium formation and single-cell lysis were significantly attenuated in cells infected with the 517A mutant virus.

Conclusions:

  • A specific region within the HIV-1 gp41 envelope glycoprotein, crucial for post-receptor binding events in cell membrane fusion, is essential for inducing HIV-1 cytopathic effects.
  • The mere presence of HIV-1 viral proteins or particles is insufficient to cause cytopathic effects; specific functional interactions mediated by viral components are required.

Related Concept Videos

Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...